TY - JOUR
T1 - The year in cardiovascular medicine 2023
T2 - the top 10 papers in thrombosis and antithrombotic treatment
AU - Andreotti, Felicita
AU - O'Donoghue, Michelle L.
AU - Ten Berg, Jurrien M.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin
AB - Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin
KW - BIVALIRUDIN
KW - HEPARIN
U2 - 10.1093/eurheartj/ehae123
DO - 10.1093/eurheartj/ehae123
M3 - Editorial
SN - 0195-668X
JO - European Heart Journal
JF - European Heart Journal
ER -